NEURODEGENERATIVE-DISEASES-DRUGS
Neurodegenerative Diseases Drugs Market to Reach US$ 62,786.2 Mn by 2026, Biogen and F. Hoffmann-La Roche Ltd Cover More than Half of the Share: Fortune Business Insights
July 25, 2019 11:25 ET | Fortune Business Insights
Pune, July 25, 2019 (GLOBE NEWSWIRE) -- The global neurodegenerative diseases drugs market’s growth is expected to derive growth from the rising prevalence of neurodegenerative diseases...